Nephrogenic Adenoma (NA) was first illustrated in 1949 by Davis, who described a case he interpreted as a "hamartoma". One year later Friedman and Kuhlenbeck described eight further examples in detail and named this lesion nephrogenic adenoma. This process is generally accepted to be metaplastic. At cystoscopy and on microscopic examination nephrogenic adenoma may simulate a neoplasm. The clinical and pathologic findings in four patients are described. The patients were two women and two men 20-60 years of age. All of them had a history of some inciting injury (infection/calculus). The four cases were initially misdiagnosed as a carcinoma. Several features of NA may cause particular diagnostic difficulty. Tiny tubules may simulate signet ring cells, the haphazard distribution of the tubules or single cell growth may also simulate the appearance of an invasive adenocarcinoma. A variety of clinical and pathologic differences should enable the distinction of these lesions. Although this is occasionally difficult. An emphasis here is placed on the diagnostic problems that they may pose for the surgical pathologist. Clinicians and pathologists should be aware about this type of lesions in order to avoid pitfalls in the diagnosis and treatment of them.

Download full-text PDF

Source

Publication Analysis

Top Keywords

nephrogenic adenoma
12
clinical pathologic
8
[nephrogenic adenoma
4
adenoma urinary
4
urinary bladder
4
bladder lesion
4
lesion confused
4
confused carcinoma
4
carcinoma report
4
report cases]
4

Similar Publications

Nephrogenic adenoma of the urinary bladder is a rare, benign lesion associated with prior inflammation or irritation of the urothelium. Although typically benign, nephrogenic adenoma can present diagnostic challenges due to its potential to mimic malignant tumors of the urinary tract. In this report, we present a case of an elderly woman with a history of recurrent urinary tract infections and bladder stone surgery who developed nephrogenic adenoma.

View Article and Find Full Text PDF

Background: Nephrogenic adenoma (NA) is a rare benign tumor that can develop at any site of the urinary system, with the bladder being the most common, followed by the urethra, ureters, renal pelvises, etc. Currently, it is unclear what the pathogenesis of NA is. This study discussed a rare case of malignant transformation from NA to mesonephric adenocarcinoma of the bladder.

View Article and Find Full Text PDF

Nephrogenic Adenoma: A Pitfall on Frozen Section of Urethral Strictures.

Int J Surg Pathol

October 2024

Department of Laboratory Medicine & Pathobiology, University of Toronto, Toronto, Canada.

Urethral strictures are a common cause of urinary obstruction which can be treated with surgical resection. Frozen sections are rare and pose a diagnostic challenge to pathologists due to the presence of benign lesions such as nephrogenic adenoma. We retrospectively examined all specimens of urethral stricture resections submitted to pathology at our institution from 2012 to 2022 (n = 258).

View Article and Find Full Text PDF

An unusual intravesical tumor: nephrogenic adenoma.

An Pediatr (Engl Ed)

August 2024

Cirugía Pediátrica, Hospital Universitari Mútua de Terrassa, Terrassa, Barcelona, Spain; Consorci Sanitari Alt Penedès i Garraf, Sant Pere de Ribes, Barcelona, Spain.

View Article and Find Full Text PDF

Nephrogenic adenomas are benign lesions that develop within the urinary tract. Most often developing within the urinary bladder, these lesions have a debatable etiopathogenesis, with hamartoma, rest hyperplasia, and transplantation of renal tubular cells being the most widely accepted ones. Nephrogenic adenomas develop more often in adult males, and predisposing factors for their development are prior urinary system injury, infection, or malignancy, with a subset of cases developing in renal transplant patients.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!